Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.5.4 is now shown, replacing the previous revision v3.5.3; this denotes a minor version update to the page rather than a content change.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change in the site release rather than the underlying study information.SummaryDifference0.0%

- Check31 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check38 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.0%

- Check60 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be an internal versioning change and does not alter study data or user-facing content.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.